8VU9
Crystal structure of wild-type HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor 5i3
Summary for 8VU9
Entry DOI | 10.2210/pdb8vu9/pdb |
Descriptor | Reverse transcriptase/ribonuclease H, p51 RT, (2E)-3-[4-({2-[(1-{[4-(methanesulfonyl)phenyl]methyl}piperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-4-yl}oxy)-3,5-dimethylphenyl]prop-2-enenitrile, ... (7 entities in total) |
Functional Keywords | non-nucleoside reverse transcriptase inhibitor, transferase, transferase-transferase inhibitor complex, viral protein, transferase-inhibitor complex, transferase/inhibitor |
Biological source | Human immunodeficiency virus type 1 BH10 More |
Total number of polymer chains | 2 |
Total formula weight | 115451.38 |
Authors | Rumrill, S.,Ruiz, F.X.,Arnold, E. (deposition date: 2024-01-29, release date: 2025-05-07, Last modification date: 2025-05-28) |
Primary citation | Wang, Z.,Rumrill, S.R.,Kang, D.,Desta, S.,Feng, D.,De Clercq, E.,Pannecouque, C.,Chen, C.H.,Arnold, E.,Ruiz, F.X.,Liu, X.,Zhan, P. Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles To Be Published, |
Experimental method | X-RAY DIFFRACTION (1.99 Å) |
Structure validation
Download full validation report
